Lai‐Chu Wu
Immunology and Microbiology · The Ohio State University
Publications
104
Citations
5,140
Est. group size
—
Recurring co-author estimate
Active years
39
Publishing since 1986
Lai-Chu Wu's research focuses on molecular mechanisms of blood cancers, particularly leukemia, examining how DNA methylation (a chemical modification that turns genes on or off) and cell signaling pathways contribute to disease. Work also touches on immune cell signaling and its role in cancers like melanoma. Studies combine cancer biology with immunology to understand how cancer cells evade normal growth controls and immune detection.
Publication output has been irregular over the last decade, with some years showing no publications and others showing bursts of activity, averaging under two publications per year over the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Supplementary Material from Inactivation of Receptor Tyrosine Kinases Reverts Aberrant DNA Methylation in Acute Myeloid Leukemia
2023
- Data from Inactivation of Receptor Tyrosine Kinases Reverts Aberrant DNA Methylation in Acute Myeloid Leukemia
2023
- Data from Inactivation of Receptor Tyrosine Kinases Reverts Aberrant DNA Methylation in Acute Myeloid Leukemia
2023
- Supplementary Material from Inactivation of Receptor Tyrosine Kinases Reverts Aberrant DNA Methylation in Acute Myeloid Leukemia
2023
- Corrigendum to “The YhhN protein of Legionella pneumophila is a Lysoplasmalogenase” [Biochim. Biophys. Acta, Biomembr. 1848 (2) (2015) 742–751]
Biochimica et Biophysica Acta (BBA) - Biomembranes · 2018
- Thymoquinone exerts potent growth-suppressive activity on leukemia through DNA hypermethylation reversal in leukemia cells
Oncotarget · 2017
- Inactivation of Receptor Tyrosine Kinases Reverts Aberrant DNA Methylation in Acute Myeloid Leukemia
Clinical Cancer Research · 2017
- Liposomal bortezomib is active against chronic myeloid leukemia by disrupting the Sp1-BCR/ABL axis
Oncotarget · 2016
- A critical role of CD200R signaling in limiting the growth and metastasis of CD200 positive melanoma
The Journal of Immunology · 2016
- The Journal of Immunology×3
- bioRxiv (Cold Spring Harbor Laboratory)×3
- Oncotarget×2
- Journal of Clinical Investigation×1
- Clinical Immunology×1
- Mark H. Kaplan
Immunology and Microbiology · Indiana University
- John W. Schrader
Immunology and Microbiology · Indiana University
- Alexander L. Dent
Immunology and Microbiology · Indiana University
- Can Li
Immunology and Microbiology · Purdue University West Lafayette
- Chang H. Kim
Immunology and Microbiology · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile